The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer.

[1]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[2]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[3]  N. Longo,et al.  Stromal Cell-Derived Factor-1α Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities , 2004, Cancer Research.

[4]  H. Band,et al.  Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells , 2004, Oncogene.

[5]  G. Watkins,et al.  Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  H. Yoshida,et al.  Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. , 2003, Experimental cell research.

[7]  R. Mansel,et al.  Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[8]  D. Jo,et al.  Production of stromal cell-derived factor-1 (SDF-1)and expression of CXCR4 in human bone marrow endothelial cells. , 2003, Journal of Korean medical science.

[9]  Meenhard Herlyn,et al.  Axis of evil: molecular mechanisms of cancer metastasis , 2003, Oncogene.

[10]  R. Mansel,et al.  Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003, International journal of cancer.

[11]  G. Watkins,et al.  Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  G. Stamatoyannopoulos,et al.  Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. , 2003, Cancer research.

[13]  Masahiro Kato,et al.  Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma , 2003, Breast Cancer Research.

[14]  Ed Roos,et al.  The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. , 2003, Cancer research.

[15]  H. Nakshatri,et al.  NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4* , 2003, Journal of Biological Chemistry.

[16]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[17]  R. Bachelder,et al.  Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. , 2002, Cancer research.

[18]  F. Nestle,et al.  Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. , 2002, Cancer research.

[19]  Oana A. Tomescu,et al.  CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. , 2002, Blood.

[20]  M. Probst-Kepper,et al.  CXCR4/CXCL12 expression and signalling in kidney cancer , 2002, British Journal of Cancer.

[21]  Evan T Keller,et al.  Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.

[22]  L. Brinton,et al.  Recent trends in breast cancer incidence and mortality , 2002, Environmental and molecular mutagenesis.

[23]  Richard J. K. Taylor,et al.  Frequency and predictors of axillary lymph node metastases in invasive breast cancer , 2001, ANZ journal of surgery.

[24]  W. Jiang,et al.  Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. , 2001, Biochemical and biophysical research communications.

[25]  Gideon Rechavi,et al.  A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma1 , 2001, The Journal of Immunology.

[26]  M. Silverstein,et al.  Predicting Axillary Nodal Positivity in 2282 Patients with Breast Carcinoma , 2001, World Journal of Surgery.

[27]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[28]  P. Kurschat,et al.  Mechanisms of metastasis , 2000, Clinical and experimental dermatology.

[29]  Craig Murdoch,et al.  CXCR4: chemokine receptor extraordinaire , 2000, Immunological reviews.

[30]  M. Imamura,et al.  Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  S. Fujita,et al.  Stromal cells in lymph nodes attractB‐lymphoma cells via production ofstromal cell‐derived factor‐1 , 2000, European journal of haematology.

[32]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[33]  Finn,et al.  Functional expression of chemokine receptor CXCR4 on human epithelial cells , 1999, Immunology.

[34]  S G Hilsenbeck,et al.  Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  R. Ganju,et al.  The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways* , 1998, The Journal of Biological Chemistry.

[36]  T. Kishimoto,et al.  A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. , 1998, Seminars in immunology.

[37]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[38]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[39]  J. Inazawa,et al.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.

[40]  T. Geiser,et al.  Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. , 1994, The Journal of biological chemistry.

[41]  W. McGuire,et al.  Prognostic indicators in early breast cancer. , 1993, The American journal of the medical sciences.